Search Results

Rifaximin pharmacology and clinical implications.

• Authors : Ojetti V; Internal Medicine Department, Catholic University of Sacred Heart, Gemelli Hospital, Rome, Italy. veronica.ojetti tin.it; Lauritano EC

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacokinetics ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Rifamycins*/Rifamycins*/Rifamycins*/pharmacokinetics

• Source: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2009 Jun; Vol. 5 (6), pp. 675-82.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print Cited Medium: Internet ISSN: 1744-7607

Record details

Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model.

• Authors : Oguri, Noriaki; Miyoshi, Jun; Nishinarita, Yuu

• Source: NPJ Biofilms & Microbiomes; 9/16/2024, Vol. 10 Issue 1, p1-11, 11p

Record details

Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and Serum Metabolites.

• Authors : Luo, Mei; Xie, Peiwei; Deng, Xuehong

• Source: Nutrients; Nov2023, Vol. 15 Issue 21, p4502, 20p

Record details

Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.

• Authors : Torre, Aldo; Córdova-Gallardo, Jacqueline; Munari, Alberto C Frati

Subjects: LIVER diseases; HEPATIC fibrosis; RIFAXIMIN

• Source: Therapeutics & Clinical Risk Management; Oct2023, Vol. 19, p839-851, 13p

Record details

Gut Microbiota and Cardiovascular System: An Intricate Balance of Health and the Diseased State.

• Authors : Bhat, Mujtaba Aamir; Mishra, Awdhesh Kumar; Tantray, Javeed Ahmad

Subjects: GUT microbiome; CARDIOVASCULAR system; HYPERTENSION risk factors

• Source: Life (2075-1729); Dec2022, Vol. 12 Issue 12, p1986, 23p

Record details

Update on gut microbiota in cardiovascular diseases.

• Authors : Buyun Qian; Kaiyu Zhang; Yuan Li

Subjects: GUT microbiome; CARDIOVASCULAR diseases; SHORT-chain fatty acids

• Source: Frontiers in Cellular & Infection Microbiology; 11/9/2022, Vol. 12, p1-9, 9p

Record details

Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases.

• Authors : Mutalub, Yahkub Babatunde; Abdulwahab, Monsurat; Mohammed, Alkali

Subjects: HEART metabolism disorders; GUT microbiome; HUMAN microbiota

• Source: Foods; Sep2022, Vol. 11 Issue 17, p2575, 35p

Record details

Rifaximin Protects against Malathion-Induced Rat Testicular Toxicity: A Possible Clue on Modulating Gut Microbiome and Inhibition of Oxidative Stress by Mitophagy.

• Authors : Omar, Nesreen Nabil; Mosbah, Rasha A.; Sarawi, Wedad S.

Subjects: GUT microbiome; OXIDATIVE stress; RIFAXIMIN

• Source: Molecules; Jul2022, Vol. 27 Issue 13, p4069-N.PAG, 26p

Record details

St. John’s Wort alleviates dextran sodium sulfate‐induced colitis through pregnane X receptor‐dependent NFκB antagonism.

• Authors : Yan, Tingting; Luo, Yuhong; Xia, Yangliu

• Source: FASEB Journal; Nov2021, Vol. 35 Issue 11, p1-17, 17p

Record details

Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats.

• Authors : Amaldos, Maria John Newton; Najar, Imtiyaz Ahmed; Kumar, Jatinder

• Source: Reports of Practical Oncology & Radiotherapy; 2021, Vol. 26 Issue 5, p712-729, 18p

Record details